Nir Lubezky
Overview
Explore the profile of Nir Lubezky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cohen-Naftaly M, Simon R, Lubezky N, Braun M, Khalaileh A, Safadi R, et al.
Harefuah
. 2024 Nov;
162(5):295-298.
PMID: 39569963
Introduction: Patients with hepatocellular carcinoma (HCC) receive Model for End-Stage Liver Disease (MELD) prioritization points. These aim to prevent waiting list drop-out due to tumor progression. This practice has resulted...
2.
Grupper A, Goykhman Y, Lubezky N, Schwartz D, Katz P, Lebedinsky A, et al.
Harefuah
. 2024 Nov;
162(5):274-278.
PMID: 39569959
Introduction: Following nephrectomy for the purpose of kidney donation, the donor has an inevitably reduced renal mass and function. Living kidney donors exhibit a higher risk of end stage renal...
3.
Barenboim A, Mercer D, Sahnan K, Gaffan A, Goren O, Halperin S, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274419
: The National Comprehensive Cancer Network (NCCN)-recommended treatment for patients with borderline-resectable pancreatic cancer (BRPC) and locally advanced pancreatic cancer (LAPC) involves a combination of neoadjuvant FOLFIRINOX chemotherapy and the...
4.
Ritter E, Shibolet O, Kessner R, Lubezky N, Ben Ami Shor D
Harefuah
. 2024 Mar;
163(3):156-163.
PMID: 38506357
Acute pancreatitis is among the most common gastrointestinal diseases, and a major cause of hospitalization and morbidity. Gallstones and alcohol abuse are the most common causes of acute pancreatitis. Other...
5.
Osher E, Geva R, Wolf I, Tordjman K, Klausner J, Sofer Y, et al.
J Clin Transl Endocrinol
. 2023 Sep;
33:100322.
PMID: 37663867
Objective: Pancreatic neuroendocrine tumors (PNETs) are rare, but their incidence has risen significantly in recent years. Whereas diabetes mellitus (DM) is recognized in association with chronic pancreatitis and pancreatic cancer,...
6.
Maman Y, Goykhman Y, Yakir O, Barenboim A, Geva R, Peles-Avraham S, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37297011
Background: The recommended treatment for resectable pancreatic cancer (PC) is resection followed by adjuvant FOLFIRINOX. We assessed the proportion of patients that managed to complete the 12 courses of adjuvant...
7.
Cohen S, Meyerovich G, Blank S, Ovdat E, Loewenstein S, Kania-Almog J, et al.
Hepatol Commun
. 2023 May;
7(6).
PMID: 37255349
Background: Short-term perioperative administration of probiotics was shown to alleviate postoperative complications and promote liver recovery among patients undergoing resection for liver malignancy. The mechanisms by which probiotic bacteria effectively...
8.
Osher E, Shalabna E, Klausner J, Greenman Y, Stern N, Shibolet O, et al.
Biomedicines
. 2023 Feb;
11(2).
PMID: 36830943
The objective of this study was to determine the prognostic value of lymph node (LN) involvement and the LN ratio (LNR) and their effect on recurrence rates and survival in...
9.
Zamir E, Zelnik Yovel D, Scapa E, Shnell M, Bar N, Bar Yishay I, et al.
Therap Adv Gastroenterol
. 2022 Nov;
15:17562848221133581.
PMID: 36353735
Background: Pancreatic cystic fluid (PCF) analysis is frequently used for cyst diagnosis with carcinoembryonic antigen (CEA) being the most accepted biomarker. Low glucose levels in PCF were previously suggested as...
10.
Younis F, Ben-Ami Shor D, Lubezky N, Geva R, Osher E, Shibolet O, et al.
Eur J Gastroenterol Hepatol
. 2022 Sep;
34(11):1111-1115.
PMID: 36170679
Background: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is a developing therapeutic approach for premalignant pancreatic-cystic neoplasms (PCNs) and small pancreatic neuroendocrine tumors (PNETs). The safety and efficacy of pancreatic EUS-RFA were...